Grupa za molekularnu biomedicinu/ Group for Molecular Biomedicine 01
The efforts of the Group for Molecular Biomedicine (GMB) are directed towards research of the molecular basis of health and disease and translational biomedicine with the aim of implementing personalized medicine based on the patient's personal genome in the health system. GMB uses next-generation sequencing technology, GWAS, and bioinformatics tools such as machine learning to monitor response to therapy and design predictive testing panels. GMB research is focused on the following topics: Pharmacogenetics/pharmacogenomics and pharmacotranscriptomics as a basis for the application of personalized medicine in the treatment of various diseases (childhood acute lymphoblastic leukemia, inflammatory bowel diseases, systemic sclerosis, COVID19, assessment of placental function in pregnant women) Hematological malignancies: identification of molecular markers for disease stratification, prognosis and adequate treatment (childhood acute leukemia, acute and chronic adult leukemia, myeloma, lymphomas) Solid tumors: application of liquid biopsy in the identification of molecular markers of prognosis, disease monitoring and therapy (non-small cell lung cancer, pancreatic cancer, gliomas), comprehensive genomic profiling (non-small cell lung cancer) COVID19: genomic profile of patients with COVID19 as insight into interindividual differences between patients with different clinical presentation Regenerative medicine: molecular basis of Buerger's disease, osteoarthritis in veterinary medicine Successful cooperation with numerous prominent centers and top scientists from EU countries resulted in joint works and partnership in significant projects. The GMB team actively participates in the education of young staff within the University of Belgrade, especially in the process of preparing multidisciplinary doctoral theses. Also, the popularization and promotion of molecular genetics, genomics and biomedicine at all levels is a constant activity of the researchers of the Molecular Biomedicine Group.
Group leader: Branka Zukic, Full Research Professor E-mail: branka.zukic@imgge.bg.ac.rs Full research Professor (Sonja Pavlović, Nataša Tošić) Associate Research Professor (Teodora Karan-Đurašević, Biljana Stanković, Nikola Kotur, Sanja Srzentić Dražilov) Assistant Research Professor (Jelena Perić, Irena Marjanović, Vladimir Gašić, Ivana Grubiša, Bojan Ristivojević) Research Assistant (Đorđe Pavlović) Junior Researcher (Marina Jelovac, Isidora Ćurić)
Најновије
-
A Comparison of MGMT Testing by MSP and qMSP in Paired Snap-Frozen and Formalin-Fixed Paraffin-Embedded Gliomas
(DiagnosticsDiagnostics, 2023) -
The pharmacogenomics of vincristine-induced peripheral neuropathy in pediatric acute lymphoblastic leukemia patients in Serbia
(Sarajevo : Institute for Genetic Engineering and Biotechnology, University of Sarajevo, 2023) -
Molecular profiling of rare thymoma using next-generation sequencing: meta-analysis
(Radiology and OncologyRadiology and Oncologythymomanext-generation sequencing (NGS)SNVs/InDelsmeta-analysis, 2023) -
Rare case of myelodysplastic syndrome with near-tetraploidy and TP53 mutation / Мијелодиспластични синдром са приближном тетраплоидијом удруженом са мутацијом гена TP53 – редак случај
(Srpski arhiv za celokupno lekarstvo, 2023) -
Signifi cance of molecular diagnosti cs in therapy of chronic lymphocytic leukemia
(Belgrade : Serbian Association on for Cancer Research, 2023) -
Pediatric acute myeloid leukemia: Insight into genetic landscape and novel targeted approaches
(Biochemical Pharmacology, 2023) -
Pharmacogenomics and pharmacotranscriptomics of acute leukemia in children: a path to personalized medicine
(Sarajevo : Institute for Genetic Engineering and Biotechnology, University of Sarajevo, 2023) -
Hybridosomes from spruce needle homogenate
(Serbian Society for Extracellular Vesicles (SrbEVs), Austrian Society for Extracellular Vesicles (ASEV), Hungarian Society for Extracellular Vesicles (HSEV), Slovenian Network for Extracellular Vesicles (SiN-EV), 2023) -
Hybridosomes from spruce needle homogenate
(Serbian Society for Extracellular Vesicles (SrbEVs), Austrian Society for Extracellular Vesicles (ASEV), Hungarian Society for Extracellular Vesicles (HSEV), Serbian Society for Extracellular Vesicles (SrbEVs), 2023) -
Micronutrients, genetics and COVID-19
(Current Opinion in Clinical Nutrition & Metabolic CareCurrent Opinion in Clinical Nutrition & Metabolic Care, 2023) -
Genomics as a basis for precision medicine
(Sarajevo : Institute for Genetic Engineering and Biotechnology, University of Sarajevo, 2023) -
Prognostic significance of the long non-coding rna malat1 expression in chronic lymphocytic leukemia
(Institute of Molecular Genetics and Genetic Engineering (IMGGE), University of Belgrade, 2023) -
Expression levels of BCL2, BAX and MDR1 as pharmacotranscriptomic and prognostic markers of prognosis in acute myeloid leukemia
(Sarajevo : Institute for Genetic Engineering and Biotechnology, University of Sarajevo, 2023) -
Association of Vitamin D, Zinc and Selenium Related Genetic Variants With COVID-19 Disease Severity
(Frontiers Media Sa, Lausanne, 2021)